Antonio Fornieles
unknownMale0.0Global Dominance: 0.00%
Antonio Fornieles is leaving the board of Oryzon Genomics, having contributed his expertise during a crucial phase of the company’s evolution in the biopharmaceutical industry.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Antonio Fornieles is set to leave the Oryzon board.
Oryzon duplica su valor en Bolsa desde enero con sus últimos avances en tratamientos en psiquiatría | EmpresasEl País·
Spain· 2025-02-24
Spain· 2025-02-24
